Long COVID Archives -

Closed up of sandglass or hourglass on background of book

With COVID-19 vaccines and therapeutics developed in rapid time, Ben Hargreaves investigates why this has not been the

Long COVID but short on treatment options

https://pharmaphorum.com/views-and-analysis/long-covid-but-short-on-treatment-options/

Clear COVID health information essential for a return to healthcare as normal

News/ News/ Patients

Large UK study suggests vaccination helps treat long COVID

Phil Taylor coronavirus, COVID-19, Long COVID, patients, UK 0 Comment

An observational study in the UK has found evidence that COVID-19 vaccination can help alleviate the lingering symptoms

Large UK study suggests vaccination helps treat long COVID

https://pharmaphorum.com/news/large-uk-study-suggests-vaccination-helps-treat-long-covid/

R&D/ Views & Analysis/ Views and analysis

NIH funds study to evaluate long-term COVID in children

Jessica Hagen Children's Hospital of Los Angeles, COVID-19, Long COVID, National Institutes of Health, NHS 0 Comment

The National Institutes of Health (NIH) is funding a nationwide study in the US to support research on

NIH funds study to evaluate long-term COVID in children

https://pharmaphorum.com/r-d/nih-funds-study-to-evaluate-long-term-covid-in-children/

News/ News/ R&D

Verily taps Oncimmune tech for ‘long COVID’ study

Phil Taylor coronavirus, COVID-19, Long COVID, oncimmune, partnering, Verily 0 Comment

Alphabet’s Verily Life Science has contracted UK biotech Oncimmune to investigate autoantibodies in people who have developed long-lasting

Verily taps Oncimmune tech for ‘long COVID’ study

https://pharmaphorum.com/news/verily-taps-oncimmune-for-long-covid-study/

News/ News/ Patients

New diagnostic finds hidden lung damage in long COVID

Phil Taylor coronavirus, COVID-19, Long COVID, patients, respiratory 0 Comment

People with long-lasting symptoms of breathlessness after COVID-19 infection may have damage to their lungs that does not

New diagnostic finds hidden lung damage in long COVID

https://pharmaphorum.com/news/new-diagnostic-finds-hidden-lung-damage-in-long-covid/

What HCPs think about COVID-19s impact on cancer diagnosis and treatment

News/ News/ Patients

UK funds ‘long COVID’ research drive as restrictions ease

Phil Taylor COVID-19, COVID-19 vaccine, Long COVID, NHS, UK 0 Comment

The UK government has provided almost £20 million ($27 million) in funding for 15 research projects aiming to

UK funds ‘long COVID’ research drive as restrictions ease

https://pharmaphorum.com/news/uk-funds-long-covid-treatment-drive-as-restrictions-ease/

News/ News/ Patients

UK study raises hopes of long COVID test within months

Phil Taylor antibodies, COVID-19, diagnostics, Long COVID 0 Comment

A diagnostic test to detect long COVID could be available within six to 12 months, following the discovery

UK study raises hopes of long COVID test within months

https://pharmaphorum.com/news/uk-study-raises-hopes-of-long-covid-test-within-months/

News/ News/ Sales and Marketing

Pharma poised to cash in on ‘long COVID’ symptoms

Richard Staines COVID-19, heart failure, idiopathic pulmonary fibrosis, infectious diseases, kidney disease, Long COVID, mental health 0 Comment

While there’s hope that vaccination campaigns may bring the pandemic under control, “long COVID” side effects may continue

Pharma poised to cash in on ‘long COVID’ symptoms

https://pharmaphorum.com/news/big-pharma-could-cash-in-on-long/

News/ News/ R&D

PureTech begins trial of potential ‘Long COVID’ drug as cases mount

Richard Staines COVID-19, infectious diseases, Long COVID, PureTech, R&D 0 Comment

As the pandemic drags on there are increasing concerns about “Long COVID” – where symptoms persist long after

PureTech begins trial of potential ‘Long COVID’ drug as cases mount

https://pharmaphorum.com/news/puretech-begins-trial-of-potential-long-covid-drug-as-cases-mount/

Trending

Long COVID

Login